Format
Sort by

Send to

Choose Destination

Search results

Items: 14

1.

Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.

Alazzam M, Tidy J, Osborne R, Coleman R, Hancock BW, Lawrie TA.

Cochrane Database Syst Rev. 2016 Jan 13;(1):CD008891. doi: 10.1002/14651858.CD008891.pub3. Review.

PMID:
26760424
2.

Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia.

Alazzam M, Tidy J, Osborne R, Coleman R, Hancock BW, Lawrie TA.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD008891. doi: 10.1002/14651858.CD008891.pub2. Review. Update in: Cochrane Database Syst Rev. 2016;1:CD008891.

PMID:
23235667
3.

Selective internal radiation therapy for liver metastases from colorectal cancer.

Townsend A, Price T, Karapetis C.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD007045. doi: 10.1002/14651858.CD007045.pub2. Review.

PMID:
19821394
4.

Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer.

Mocellin S, Pasquali S, Nitti D.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007823. doi: 10.1002/14651858.CD007823.pub2. Review.

PMID:
19588444
5.

Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era?

Mocellin S, Pilati P, Lise M, Nitti D.

J Clin Oncol. 2007 Dec 10;25(35):5649-54. Review.

PMID:
18065736
6.

A phase II study of irinotecan in combination with doxifluridine, an intermediate form of capecitabine, in patients with metastatic colorectal cancer.

Kato T, Mishima H, Ikenaga M, Murata K, Ishida H, Fukunaga M, Ota H, Tominaga S, Ohnishi T, Amano M, Ikeda K, Ikeda M, Sekimoto M, Sakamoto J, Monden M.

Cancer Chemother Pharmacol. 2008 Feb;61(2):275-81. Epub 2007 Apr 11.

PMID:
17429630
7.

Complications of hepatic artery infusion: a review of 4580 reported cases.

Barnett KT, Malafa MP.

Int J Gastrointest Cancer. 2001;30(3):147-60. Review.

PMID:
12540027
8.

[Evidence for and practical use of arterial infusion chemotherapy for liver metastases].

Arai Y, Matsueda K, Inaba Y, Aramaki T.

Gan To Kagaku Ryoho. 2002 Feb;29(2):182-8. Review. Japanese.

PMID:
11865622
9.

Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis. Meta-Analysis Group in Cancer.

Buyse M, Thirion P, Carlson RW, Burzykowski T, Molenberghs G, Piedbois P.

Lancet. 2000 Jul 29;356(9227):373-8.

PMID:
10972369
11.

Economic implications of hepatic arterial infusion chemotherapy in treatment of nonresectable colorectal liver metastases. Meta-Analysis Group in Cancer.

Durand-Zaleski I, Roche B, Buyse M, Carlson R, O'Connell MJ, Rougier P, Chang AE, Sondak VK, Kemeny MM, Allen-Mersh TG, Fagniez PL, Le Bourgeois JP, Piedbois P.

J Natl Cancer Inst. 1997 Jun 4;89(11):790-5.

12.

Hepatic arterial infusion for metastatic colorectal cancer: the price of "success".

Ruffin WK.

Am J Gastroenterol. 1996 Nov;91(11):2444-5. No abstract available.

PMID:
8931443
14.

Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer.

Meta-Analysis Group in Cancer, Piedbois P, Buyse M, Kemeny N, Rougier P, Carlson R, Allen-Mersh T, O'Connell M, Chang A, Sondak V, Kemeny M, Levy E.

J Natl Cancer Inst. 1996 Mar 6;88(5):252-8.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk